MYD88 and Bloom syndrome: In mice that were IL‐1R1 deficient or MyD88 deficient, or administration of IL‐1 receptor antagonist (Anakinet) abrogated responses to BLM, such as the release of pro‐inflammatory cytokines, pulmonary inflammation and fibrosis 8.